Expertise in
5
conditions

Zhiwei H. Zhou

Guangzhou, CN 
Expertise in
5
conditions
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Zhiwei Zhou practices in Guangzhou, China. Zhou is highly rated in 5 conditions, according to our data. Their top areas of expertise are Stomach Cancer, Gastrointestinal Stromal Tumor, Pancreatic Islet Cell Tumor, Gastrectomy, and Nephrectomy.

Their clinical research consists of co-authoring 139 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Guangzhou, China
Other Locations
Shanghai, China
Hengyang, 421002, China
No. 818 Renmin Road, Changde, 415003, China
Macau, China
Key Laboratory For Green Organic Synthesis And Application Of Hunan Province, Key Laboratory Of Environmentally Friendly Chemistry And Application Of Ministry Of Education, Xiangtan, 411105, China
Changsha, China
Department Of Otorhinolaryngology Head And Neck Surgery, Foshan, 528000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Surufatinib Compared to Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Surufatinib Compared to Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Enrollment Status: Completed
Publish Date: March 30, 2023
Intervention Type: Other, Drug
Study Drug: Surufatinib
Study Phase: Phase 3
A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Surufatinib Compared to Placebo in Patients With Advanced Pancreatic Neuroendocrine Tumors
A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Surufatinib Compared to Placebo in Patients With Advanced Pancreatic Neuroendocrine Tumors
Enrollment Status: Completed
Publish Date: March 30, 2023
Intervention Type: Other, Drug
Study Drug: Surufatinib
Study Phase: Phase 3
View 1 Less Clinical Trial

139 Total Publications

Green Recovery of Precious Metals from E-waste via Autocatalytic Leaching.
Green Recovery of Precious Metals from E-waste via Autocatalytic Leaching.
Journal: Angewandte Chemie (International ed. in English)
Published: October 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile